Hepcidin is an antibacterial, stress-inducible peptide of the biliary system

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Strnad, Pavel ^a   Schwarz, Peggy ^a   Rasenack, Maria C D ^a   Kucukoglu, Ozlem ^a   Habib, Rayan I ^a   Heuberger, Dominik ^b   Ehehalt, Robert ^b   Müller, Michael W ^c   Stieh, Adolf ^b   Adler, Guido ^a   Kulaksiz, Hasan ^a,b  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c Nephrology Center Stuttgart   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; C REACTIVE PROTEIN; HEPCIDIN; INTERLEUKIN 6; MESSENGER RNA; POLYPEPTIDE ANTIBIOTIC AGENT; PROHEPCIDIN; ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE;

ANIMAL TISSUE; ARTICLE; BILE; BILIRUBIN BLOOD LEVEL; COMMON BILE DUCT; CONTROLLED STUDY; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; GALLBLADDER; GUINEA PIG; HEPATOBILIARY SYSTEM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN VITRO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIMARY SCLEROSING CHOLANGITIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; ANIMAL; BILE DUCT; CHEMISTRY; EPITHELIUM CELL; GENETICS; METABOLISM; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGICAL STRESS; PHYSIOLOGY; SCLEROSING CHOLANGITIS; TRANSCRIPTION INITIATION;

BACTERIA (MICROORGANISMS); MUS;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BILE DUCTS; BILIARY TRACT; CHOLANGITIS, SCLEROSING; EPITHELIAL CELLS; GALLBLADDER; HUMANS; INTERLEUKIN-6; MICE; STRESS, PHYSIOLOGICAL; TRANSCRIPTIONAL ACTIVATION;

EID: 79551557907     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016454     Document Type: Article

References (29)

1. Knutson MD (2010) Iron-Sensing Proteins that Regulate Hepcidin and Enteric Iron Absorption. Annu Rev Nutr 30: 149-171.
2. Wessling-Resnick M (2010) Iron Homeostasis and the Inflammatory Response. Annu Rev Nutr 30: 105-122.
3. Kemna EH, Tjalsma H, Willems HL, Swinkels DW (2008) Hepcidin: from discovery to differential diagnosis. Haematologica 93: 90-97.
4. Viatte L, Vaulont S (2009) Hepcidin, the iron watcher. Biochimie 91: 1223-1228.
5. Pietrangelo A (2007) Hemochromatosis: an endocrine liver disease. Hepatology 46: 1291-1301.
6. Verga Falzacappa MV, Muckenthaler MU (2005) Hepcidin: iron-hormone and anti-microbial peptide. Gene 364: 37-44.
7. Ganz T (2009) Iron in innate immunity: starve the invaders. Curr Opin Immunol 21: 63-67.
8. Ashrafian H (2003) Hepcidin: the missing link between hemochromatosis and infections. Infect Immun 71: 6693-6700.
9. Kulaksiz H, Theilig F, Bachmann S, Gehrke SG, Rost D, et al. (2005) The ironregulatory peptide hormone hepcidin: expression and cellular localization in the mammalian kidney. J Endocrinol 184: 361-370.
10. Kulaksiz H, Fein E, Redecker P, Stremmel W, Adler G, et al. (2008) Pancreatic beta-cells express hepcidin, an iron-uptake regulatory peptide. J Endocrinol 197: 241-249.
11. Merle U, Fein E, Gehrke SG, Stremmel W, Kulaksiz H (2007) The iron regulatory peptide hepcidin is expressed in the heart and regulated by hypoxia and inflammation. Endocrinology 148: 2663-2668.
12. Bekri S, Gual P, Anty R, Luciani N, Dahman M, et al. (2006) Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology 131: 788-796.
13. Arnold J, Sangwaiya A, Manglam V, Geoghegan F, Thursz M, et al. (2010) Presence of hepcidin-25 in biological fluids: bile, ascitic and pleural fluids. World J Gastroenterol 16: 2129-2133.
14. Marques F, Falcao AM, Sousa JC, Coppola G, Geschwind D, et al. (2009) Altered iron metabolism is part of the choroid plexus response to peripheral inflammation. Endocrinology 150: 2822-2828.
15. Brissot P, Bolder U, Schteingart CD, Arnaud J, Hofmann AF (1997) Intestinal absorption and enterohepatic cycling of biliary iron originating from plasma non-transferrin-bound iron in rats. Hepatology 25: 1457-1461.
16. Chen XM, O'Hara SP, LaRusso NF (2008) The immunobiology of cholangiocytes. Immunol Cell Biol 86: 497-505.
17. Begley M, Gahan CG, Hill C (2005) The interaction between bacteria and bile. FEMS Microbiol Rev 29: 625-651.
18. Wuestefeld T, Klein C, Streetz KL, Beraza N, Scholmerich J, et al. (2005) Lack of gp130 expression results in more bacterial infection and higher mortality during chronic cholestasis in mice. Hepatology 42: 1082-1090.
19. Kulaksiz H, Gehrke SG, Janetzko A, Rost D, Bruckner T, et al. (2004) Prohepcidin: expression and cell specific localisation in the liver and its regulation in hereditary haemochromatosis, chronic renal insufficiency, and renal anaemia. Gut 53: 735-743.
20. Storto PD, Saidman SL, Demetris AJ, Letessier E, Whiteside TL, et al. (1990) Chromosomal breakpoints in cholangiocarcinoma cell lines. Genes Chromosomes Cancer 2: 300-310.
21. Knuth A, Gabbert H, Dippold W, Klein O, Sachsse W, et al. (1985) Biliary adenocarcinoma. Characterisation of three new human tumor cell lines. J Hepatol 1: 579-596.
22. Zhong B, Strnad P, Toivola DM, Tao GZ, Ji X, et al. (2007) Reg-II is an exocrine pancreas injury-response product that is up-regulated by keratin absence or mutation. Mol Biol Cell 18: 4969-4978.
23. Punnonen EL, Fages C, Wartiovaara J, Rauvala H (1999) Ultrastructural localization of beta-actin and amphoterin mRNA in cultured cells: application of tyramide signal amplification and comparison of detection methods. J Histochem Cytochem 47: 99-112.
24. Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, et al. (2003) Hepcidin, a putative mediator of anemia of inflammation, is a type II acutephase protein. Blood 101: 2461-2463.
25. Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, et al. (2002) The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 110: 1037-1044.
26. Huang YH, Chuang JH, Yang YL, Huang CC, Wu CL, et al. (2009) Cholestasis downregulate hepcidin expression through inhibiting IL-6-induced phosphorylation of signal transducer and activator of transcription 3 signaling. Lab Invest 89: 1128-1139.
27. Kroot JJ, Hendriks JC, Laarakkers CM, Klaver SM, Kemna EH, et al. (2009) (Pre)analytical imprecision, between-subject variability, and daily variations in serum and urine hepcidin: implications for clinical studies. Anal Biochem 389: 124-129.
28. Zhang X, Jin M, Wu H, Nadasdy T, Nadasdy G, et al. (2008) Biomarkers of lupus nephritis determined by serial urine proteomics. Kidney Int 74: 799-807.
29. Wenderfer SE, Dubinsky WP, Hernandez-Sanabria M, Braun MC (2009) Urine proteome analysis in murine nephrotoxic serum nephritis. Am J Nephrol 30: 450-458.